Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1426
First IPO Date
August 20, 1992
Key Executives
| Name | Title | Pay | Year Born |
| Kejing Wu | Board Secretary | 0 | 1977 |
| Zhimian Chen | Chief Financial Officer & Director | 0 | 1971 |
| Feng Bin | GM & Director | 0 | 1972 |
| Xiajuan Wang | Accounting Supervisor | 0 | N/A |
Description
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., through its various subsidiaries, functions as a pharmaceutical manufacturing holding and investment entity within China. The company's operations encompass the research, development, and production of a broad spectrum of medications. Its therapeutic focus includes pharmaceuticals for oncology, cardiovascular and cerebrovascular conditions, respiratory issues (such as colds and coughs), pediatric care, and antifungal treatments, alongside general health tonics. The firm's product portfolio features both prescription-only drugs and readily available over-the-counter (OTC) remedies. Established in Shanghai, China, in 1992, the company continues to operate from this location.